Activity Overview
The Interstitial Lung Disease Insights: Meet the Professor Virtual Series I, is a live, case-based program designed to enhance clinicians’ ability to recognize and manage interstitial lung disease associated with systemic autoimmune rheumatic diseases. Through expert-led presentations, the series highlights evidence-based approaches to early detection, risk-based screening, diagnostic evaluation, and longitudinal care, while promoting interdisciplinary collaboration and informed clinical decision-making to improve patient outcomes.
This session builds on these foundations by focusing on the early detection, diagnosis, and management of interstitial lung disease using a case-based approach. Faculty will demonstrate how to integrate clinical presentation, laboratory and autoantibody testing, imaging, and pulmonary function data to improve diagnostic accuracy, guide risk-based screening, and apply practical strategies for monitoring, prognosis, and multidisciplinary care.
Activity Overview
The Interstitial Lung Disease Insights: Meet the Professor Virtual Series I, is a live, case-based program designed to enhance clinicians’ ability to recognize and manage interstitial lung disease associated with systemic autoimmune rheumatic diseases. Through expert-led presentations, the series highlights evidence-based approaches to early detection, risk-based screening, diagnostic evaluation, and longitudinal care, while promoting interdisciplinary collaboration and informed clinical decision-making to improve patient outcomes.
This session builds on these foundations by focusing on the early detection, diagnosis, and management of interstitial lung disease using a case-based approach. Faculty will demonstrate how to integrate clinical presentation, laboratory and autoantibody testing, imaging, and pulmonary function data to improve diagnostic accuracy, guide risk-based screening, and apply practical strategies for monitoring, prognosis, and multidisciplinary care.
Activity Overview
This live interdisciplinary webinar will explore the expanding role of glucagon-like peptide-1 receptor agonists beyond diabetes and obesity, with a focus on their relevance in rheumatology care. Designed for rheumatologists, endocrinologists, pharmacists, advanced practice providers, and primary care clinicians, the session will examine the intersection of metabolic disease and inflammatory conditions through a case-based, clinically practical lens. Key themes include glucagon-like peptide-1 receptor agonists, rheumatology, obesity, inflammatory arthritis, osteoarthritis, metabolic disease, interdisciplinary care, pharmacotherapy, access, safety, ethics, and clinical decision-making.
Through expert-led presentations and interactive discussion, this activity will highlight emerging evidence and practical applications in rheumatic disease.
Learning Objectives
Upon completion of this activity, learners should be able to:
Explain the metabolic and systemic mechanisms of GLP 1 receptor agonists relevant to rheumatology patients
Evaluate emerging evidence in osteoarthritis, inflammatory arthritis, and comorbid conditions
Identify appropriate patient candidates and interdisciplinary care considerations
Assess access barriers, safety issues, and ethical implications
Apply case-based frameworks for real-world clinical decision-making
Target Audience
Advanced practice nurses, dieticians, endocrinologists, health educators, health services researchers, nurses, occupational therapists, pharmacists, primary care providers, physical therapists, physician assistants, researchers, rheumatologists, and rheumatology interprofessionals
CE/MOC Information
This activity is not eligible for credit.